This topic contains a solution. Click here to go to the answer

Author Question: Clinically effective antidepressants in present use differ primarily with respect to their a. ... (Read 46 times)

imanialler

  • Hero Member
  • *****
  • Posts: 539
Clinically effective antidepressants in present use differ primarily with respect to their
 
  a. potency in blocking cholinergic activity
  b. relative affinity for serotonin and norepinephrine reuptake systems
  c. relative ability to reduce monoamine oxidase activity
  d. all of the above

Question 2

One of the primary differences among the drugs classified as traditional tricyclic antidepressants is their
 
  a. relative efficacy in relieving depression
  b. tendency to induce anticholinergic side effects
  c. relative potency in blocking the reuptake of cyclic AMP
  d. none of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

rachel

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

d

Answer to Question 2

d




imanialler

  • Member
  • Posts: 539
Reply 2 on: Jun 22, 2018
Wow, this really help


ktidd

  • Member
  • Posts: 319
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library